Universe Pharmaceuticals (UPC) Competitors $6.71 -0.51 (-7.06%) Closing price 04:00 PM EasternExtended Trading$6.32 -0.40 (-5.89%) As of 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock UPC vs. APM, AEON, BFRI, MTNB, EPIX, ADXN, ALBT, IMCC, KPRX, and HCWBShould you be buying Universe Pharmaceuticals stock or one of its competitors? The main competitors of Universe Pharmaceuticals include Aptorum Group (APM), AEON Biopharma (AEON), Biofrontera (BFRI), Matinas Biopharma (MTNB), ESSA Pharma (EPIX), Addex Therapeutics (ADXN), Avalon GloboCare (ALBT), IM Cannabis (IMCC), Kiora Pharmaceuticals (KPRX), and HCW Biologics (HCWB). These companies are all part of the "pharmaceutical products" industry. Universe Pharmaceuticals vs. Its Competitors Aptorum Group AEON Biopharma Biofrontera Matinas Biopharma ESSA Pharma Addex Therapeutics Avalon GloboCare IM Cannabis Kiora Pharmaceuticals HCW Biologics Universe Pharmaceuticals (NASDAQ:UPC) and Aptorum Group (NASDAQ:APM) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, media sentiment, earnings, analyst recommendations, institutional ownership, profitability and risk. Does the media favor UPC or APM? In the previous week, Aptorum Group had 4 more articles in the media than Universe Pharmaceuticals. MarketBeat recorded 10 mentions for Aptorum Group and 6 mentions for Universe Pharmaceuticals. Universe Pharmaceuticals' average media sentiment score of 0.48 beat Aptorum Group's score of 0.31 indicating that Universe Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Universe Pharmaceuticals 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Aptorum Group 1 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts rate UPC or APM? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Universe Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Aptorum Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Which has more risk & volatility, UPC or APM? Universe Pharmaceuticals has a beta of 1.49, meaning that its share price is 49% more volatile than the S&P 500. Comparatively, Aptorum Group has a beta of 0.27, meaning that its share price is 73% less volatile than the S&P 500. Do insiders and institutionals have more ownership in UPC or APM? 0.2% of Universe Pharmaceuticals shares are owned by institutional investors. Comparatively, 3.8% of Aptorum Group shares are owned by institutional investors. 57.4% of Universe Pharmaceuticals shares are owned by company insiders. Comparatively, 64.0% of Aptorum Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has higher earnings and valuation, UPC or APM? Aptorum Group has lower revenue, but higher earnings than Universe Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUniverse Pharmaceuticals$19.29M0.20-$8.73MN/AN/AAptorum GroupN/AN/A-$4.27MN/AN/A Is UPC or APM more profitable? Company Net Margins Return on Equity Return on Assets Universe PharmaceuticalsN/A N/A N/A Aptorum Group N/A N/A N/A SummaryAptorum Group beats Universe Pharmaceuticals on 4 of the 7 factors compared between the two stocks. Get Universe Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for UPC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding UPC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UPC vs. The Competition Export to ExcelMetricUniverse PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.78M$2.58B$6.01B$10.23BDividend YieldN/A56.68%5.66%4.69%P/E RatioN/A22.9185.3526.57Price / Sales0.20602.30583.22179.26Price / CashN/A177.3038.3262.20Price / Book0.005.3712.726.53Net Income-$8.73M$32.78M$3.30B$275.96M7 Day Performance42.46%2.39%1.05%-1.40%1 Month Performance74.74%10.26%7.56%5.16%1 Year PerformanceN/A-0.21%79.69%31.55% Universe Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UPCUniverse Pharmaceuticals0.5825 of 5 stars$6.71-7.1%N/AN/A$3.78M$19.29M0.00220Analyst ForecastShort Interest ↑Gap DownAPMAptorum Group0.921 of 5 stars$1.85+3.4%N/A+37.0%$9.89MN/A0.0030News CoverageAnalyst ForecastShort Interest ↓Trading HaltedAEONAEON Biopharma0.9274 of 5 stars$0.84+8.1%$360.00+42,655.3%-98.7%$9.80MN/A4.685Analyst ForecastGap UpBFRIBiofrontera2.3513 of 5 stars$0.960.0%$2.75+186.5%+25.2%$9.73M$37.32M-0.4270Analyst ForecastShort Interest ↓MTNBMatinas BiopharmaN/A$1.90+1.1%N/AN/A$9.67MN/A-0.3930Gap DownEPIXESSA Pharma3.7947 of 5 stars$0.20+0.4%$2.00+895.0%-96.7%$9.51MN/A-0.3650News CoverageDividend AnnouncementAnalyst ForecastADXNAddex Therapeutics0.7039 of 5 stars$8.87-1.9%$30.00+238.2%-11.5%$9.47M$170.62K-26.0930Gap UpALBTAvalon GloboCare1.6006 of 5 stars$2.46+2.5%N/A-24.4%$9.43M$1.33M-0.125Positive NewsAnalyst ForecastGap UpIMCCIM Cannabis0.6602 of 5 stars$1.77-0.6%N/A-12.9%$9.29M$39.44M-3.28340Analyst ForecastGap UpKPRXKiora Pharmaceuticals3.2646 of 5 stars$2.61+1.6%$10.00+283.1%-16.1%$8.96M$16.02M-0.9010Positive NewsAnalyst ForecastHCWBHCW Biologics1.6332 of 5 stars$4.09+0.2%$35.00+755.7%-79.4%$8.80M$2.57M-0.2940News CoveragePositive NewsAnalyst Forecast Related Companies and Tools Related Companies Aptorum Group Alternatives AEON Biopharma Alternatives Biofrontera Alternatives Matinas Biopharma Alternatives ESSA Pharma Alternatives Addex Therapeutics Alternatives Avalon GloboCare Alternatives IM Cannabis Alternatives Kiora Pharmaceuticals Alternatives HCW Biologics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:UPC) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenIf you're a futures trader (or want to be one), this could be the biggest shift you'll ever see in the prop fi...Neuro Street Trading Academy | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredThe 7 Warning Signals Flashing Red Right NowA free report revealing the 7 key indicators that have predicted every major economic collapse since 1929. ...American Alternative | Sponsored"I'm risking my reputation on this"If I'm right about what's coming, this could be the most important book you'll read this yearCrypto 101 Media | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Universe Pharmaceuticals INC Please log in to your account or sign up in order to add this asset to your watchlist. Share Universe Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
